Impact on optical coherence tomographic coronary findings of fluvastatin alone versus fluvastatin + ezetimibe

American Journal of Cardiology

Volumn 113, Issue 4, 2014, Pages 580-587

  Habara, Maoto ^a   Nasu, Kenya ^a   Terashima, Mitsuyasu ^a   Ko, Euihong ^a   Yokota, Daisuke ^a   Ito, Tsuyoshi ^a   Kurita, Tairo ^a   Teramoto, Tomohiko ^a   Kimura, Masashi ^a   Kinoshita, Yoshihisa ^a   Tsuchikane, Etsuo ^a   Asakura, Yasushi ^a   Matsubara, Tetsuo ^a   Suzuki, Takahiko ^a  

^a Toyohashi Heart Center Toyohashi   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHOLESTEROL, LDL; CORONARY VESSELS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FATTY ACIDS, MONOUNSATURATED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDOLES; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84895068065     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.10.038     Document Type: Article

References (18)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
2. J. Shepherd Preventing coronary artery disease in the West of Scotland: implications for primary prevention Am J Cardiol 82 1998 57T 59T
3. S.J. Nicholls, E.M. Tuzcu, I. Sipahi, A.W. Grasso, P. Schoenhagen, T. Hu, K. Wolski, T. Crowe, M.Y. Desai, S.L. Hazen, S.R. Kapadia, and S.E. Nissen Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis JAMA 297 2007 499 508
4. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole, L. Brown, J.W. Warnica, J.M. Arnold, C.C. Wun, B.R. Davis, and E. Braunwald The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
5. K. Nasu, E. Tsuchikane, O. Katoh, N. Tanaka, M. Kimura, M. Ehara, Y. Kinoshita, T. Matsubara, H. Matsuo, K. Asakura, Y. Asakura, M. Terashima, T. Takayama, J. Honye, A. Hirayama, S. Saito, and T. Suzuki Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound JACC Cardiovasc Interv 2 2009 689 696
6. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen, T. Crowe, W.J. Sasiela, J. Tsai, J. Orazem, R.D. Magorien, C. O'Shaughnessy, P. Ganz Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease N Engl J Med 352 2005 29 38
7. T.E. Strandberg, R.S. Tilvis, K.H. Pitkala, and T.A. Miettinen Cholesterol and glucose metabolism and recurrent cardiovascular events among the elderly: a prospective study J Am Coll Cardiol 48 2006 708 714
8. E. Stein, S. Stender, P. Mata, P. Sager, D. Ponsonnet, L. Melani, L. Lipka, R. Suresh, D. Maccubbin, E. Veltri Ezetimibe Study Group Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin Am Heart J 148 2004 447 455
9. T. Kovarnik, G.S. Mintz, H. Skalicka, A. Kral, J. Horak, R. Skulec, J. Uhrova, P. Martasek, R.W. Downe, A. Wahle, M. Sonka, V. Mrazek, M. Aschermann, and A. Linhart Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: HEAVEN study Circ J 76 2012 176 183
10. I.K. Jang, B.E. Bouma, D.H. Kang, S.J. Park, S.W. Park, K.B. Seung, K.B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S.L. Houser, H.T. Aretz, and G.J. Tearney Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound J Am Coll Cardiol 39 2002 604 609
11. T. Ito, M. Terashima, H. Kaneda, K. Nasu, H. Matsuo, M. Ehara, Y. Kinoshita, M. Kimura, N. Tanaka, M. Habara, O. Katoh, and T. Suzuki Comparison of in vivo assessment of vulnerable plaque by 64-slice multislice computed tomography versus optical coherence tomography Am J Cardiol 107 2011 1270 1277
12. I.K. Jang, G.J. Tearney, B. MacNeill, M. Takano, F. Moselewski, N. Iftima, M. Shishkov, S. Houser, H.T. Aretz, E.F. Halpern, and B.E. Bouma In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography Circulation 111 2005 1551 1555
13. T. Kume, T. Akasaka, T. Kawamoto, H. Okura, N. Watanabe, E. Toyota, Y. Neishi, R. Sukmawan, Y. Sadahira, and K. Yoshida Measurement of the thickness of the fibrous cap by optical coherence tomography Am Heart J 152 2006 755.e1 755.e4
14. T.A. Miettinen, R.S. Tilvis, and Y.A. Kesäniemi Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population Am J Epidemiol 131 1990 20 31
15. J.R. McNamara, and E.J. Schaefer Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions Clin Chim Acta 166 1987 1 8
16. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
17. K. Nasu, M. Terashima, M. Habara, E. Ko, T. Ito, D. Yokota, S. Ishizuka, T. Kurita, M. Kimura, Y. Kinoshita, Y. Asakura, E. Tsuchikane, O. Katoh, and T. Suzuki Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography JACC Cardiovasc Interv 6 2013 746 755
18. N.R. Matthan, M. Pencina, J.M. LaRocque, P.F. Jacques, R.B. D'Agostino, E.J. Schaefer, and A.H. Lichtenstein Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD J Lipid Res 50 2009 1927 1935